THERAPEUTIC PARAMETERS AND MECHANISM OF ACTION OF ANTI-MIR-17 DRUGS IN ADPKD

$1,640,000FY2025Defense Health AgencyDOD

The University Of Texas Southwestern Medical Center

Investigators